Innovation Compounding Opens New 20,000-Square-Foot Pharmacy Facility in Georgia

Image Courtesy: Public Domain

Innovation Compounding, a 503A compounding pharmacy and member of the Revelation Pharmanational network, opens a new 20,000-square-foot facility at 3330 Chastain Meadows Pkwy NW, Suite 100, in Kennesaw, Georgia. The location brings sterile and non-sterile compounding services under one roof, adding operational capacity to one of the network's flagship pharmacies.

The expansion builds on nearly two decades of growth. Innovation Compounding ships more than 350,000 patient-specific prescriptions annually to patients across the United States, and the new facility positions it to grow that reach across a broad range of therapeutic areas including women's health, men's health, pain management, weight management, chronic disease, animal health, and drug shortage solutions.

Investing in the Future of Pharmacy

"The future of patient-centered compounding is about meeting patients where they are, with medications built around their specific needs rather than a one-size-fits-all solution," said Shawn Hodges, CEO, Revelation Pharma. "This facility puts us in a position to lead that charge, and we are just getting started."

Growing the Revelation Pharma Network 

Revelation Pharma continues to invest in the infrastructure and partnerships that allow its network of pharmacies to deliver patient-centered care at scale. The Kennesaw facility reflects that commitment and advances the network's mission to expand access to high-quality compounded medications nationwide.